We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Pedro Coelho, Founder and CEO at Biorce! In this episode, I sit down with Coelho to explore how his team went from flagging protocol mistakes to building AI that fixes them — and in doing so, became the first company to submit an AI-generated protocol to the FDA. Coehlo breaks down how Biorce can generate a best-in-class clinical trial protocol in under 5 minutes, why risk-based remote monitoring is the industry’s biggest anti-pattern, and what a “one-click clinical trial” could look like by the end of 2026.

Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

• Tell me about your journey – how does a European Founder like you, and a team like yours, get into a space that traditionally has been filled with American companies?
• What is your value creation?
• What is your business model? How do you make money from getting it right faster?
• What are three things you want to do for your customers in 2026?
• What is the biggest anti-pattern in clin-ops today?

Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.

Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:

• Apple Podcasts
• Spotify
• iHeartRadio
• Amazon Music
• Pandora
• YouTube

Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.

If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

Thanks so much for listening!

We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Alison Holland, Chief Customer Officer at Medable! In this episode, I talk with Holland about how her journey from London nurse to Covance veteran to digital trial leader shapes Medable’s strategy.

Holland started at the bedside and then spent nearly 20 years at a major CRO – Covance. She learned where trials really break: overloaded sites, fragmented systems, and patients battling logistics instead of disease. Medable’s answer is a reusable SaaS platform plus tightly scoped AI agents—first for CRAs, then for TMF, and next for sites—that automate the manual, low‑value work while keeping humans firmly in the loop.

She walks through concrete wins: PRO compliance jumping from ~75% to 95%, 20% more primary endpoint data, and up to 100 hours saved in study startup by configuring from therapeutic‑area libraries instead of rebuilding from scratch.

Holland’s chosen industry anti‑pattern is “change fatigue”: an exhausted ecosystem that no longer believes transformation will stick. Her counter is precision use cases that deliver undeniable value, build momentum, and make it possible to say, credibly, “Yes, we can” this time.

Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

• Tell me about your journey.
• Who are your customers and how do you create value for them?
• What’s Medable’s sweet spot for the size of the customer, the kind of customer, or the phase of the study?
• We saw this recurring pattern where the decisions would be taken in the last month before the trial, and a subpattern where, in the first two weeks, there would very often be a protocol revision. Is that your experience as well?
• Do you have to do a custom build for every customer and every trial?
• How do you capture the value?
• Are we going to see AI Agents replacing CROs in our lifetime?
• What are three things you want to do for your customers in 2026?
• What is the biggest anti-pattern in the clinical R&D industry today?

Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.

Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:

• Apple Podcasts
• Spotify
• iHeartRadio
• Amazon Music
• Pandora
• YouTube

Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.

If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

Thanks so much for listening!